Claim up to 50% off and get premium data CLAIM OFFER Exchange Data 162.95 USD Price -0.42 (-0.26%) Day change 143.13 - 165.83 52-week range Summary of Johnson & Johnson Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in th...
Stock quote Stock quote information. Pricing delayed by 20 minutes. Last updated 11/22/2024 4:00 PM Price$155.17Volume8,265,961 Change-0.33% Change-0.21% Today's open$155.90Previous close$155.50 Intraday high$157.12Intraday low$154.11
Trading up+0.46(+0.15%) at 311.85. Countertrend Down (-85) - SPGSUCE is showing short-term strength. However, look for the longer-term bearish trend to resume. As always, continue to monitor the trend score and set stops. Foreign Exchange ...
Johnson & Johnson (JNJ) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings.Create Free Account JNJ Johnson & Johnson Stock Price & Overview Follow417.07K followers $150.47-1.89 (-1.24%)4:00 PM 12/04/24 NYSE | $USD | Pre-Market: $150.89 +0.42 (+0.28%)...
强生公司业绩喜忧参半 强生公司(纽约证券交易所代码:JNJ)是股票中的主力军,任何投资者都可以拥有。该公司的业务不仅根深蒂固,它的交易价格通常低于标准普尔 500 指数,它实现了稳定的持续增长,并且支付了可观的股息。这就是为什么在只能称为混合报告之后看到它走高并
Stay up to date with the latest Johnson & Johnson stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on JNJ:CA here.
Stock report for JNJ - Johnson & Johnson including beta, volatilty estimates, value-at-risk, support and resistance levels, and key moving averages.
Get Johnson & Johnson (JNJ:NYSE) real-time stock quotes, news, price and financial information from CNBC.
Current Price $144.36 NASDAQ: EXEL Exelixis Market Cap $10B Current Price $35.93 NASDAQ: GILD Gilead Sciences Market Cap $115B Current Price $92.41 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium...